Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN116731988B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116731988B reveals high-purity pharmaceutical intermediates synthesis via engineered ketoreductase, ensuring supply chain reliability and cost reduction.